Friday, August 16, 2019

Recent Trends in Oncology


FDA granted approval to entrectinib for the treatment of adults and children with cancers that harbor NTRK, gene fusion and for whom there are no effective treatments. Learn more about oncology at: http://bit.ly/2Yxiv66

No comments:

Post a Comment